P15.02 Phase Ib Study to Evaluate the Safety and Efficacy of Osimertinib in Combination with Ipilimumab in EGFR Mutated NSCLC
Year: 2021
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: S. Puri, S. Patel, A. Chalmers, K. Kerrigan, E. Loertscher, S. George, K. Boucher, W. Akerley
Institution: Huntsman Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3137229904